johnson

New York Stock Exchange Suspends Trading, Cites Technical …

All trading has halted on the New York Stock Exchange, and the NYSE would like everyone to know that it’s the result of an internal technical screwup and not a cyberattack.The NYSE stopped trading all securities around 11:32 am, without much explanation about what went down. Since no one exchange handles more than 16% of trading, this isn’t a catastrophe […]

Can It Get Worse For LeapFrog? – Benzinga

Related LFStocks Hitting 52-Week LowsMorning Market LosersEven A Kiss From A Princess Can’t Save LeapFrog(Seeking Alpha)In a report published Monday, BMO Capital Markets analyst Gerrick L. Johnson maintained an Outperform rating on LeapFrog Enterprises, Inc. (NYSE: LF), while reducing the price target from $8 to $4, saying that the company is “leaping backwards.”LeapFrog accounted its F4Q EPS at a loss […]

Stock Market News for April 15, 2015 – Zacks Investment Research

Benchmarks finished mostly in the green on Tuesday, banking on gains in energy shares which were powered by a rise in oil prices. However, the Nasdaq settled in the red due to overall weakness in the technology sector. Meanwhile, investors remained focused on mixed earnings results and weaker than expected retail sales.For a look at the issues currently facing the […]

Big chance to buy biotech?

In fact, biotech stocks have been so strong that “you could see these stocks off another 10 percent from here, and still be in an uptrend,” Johnson said. “We’d be buying these names on the pullback.”The fundamentals also remain supportive of biotech, says David Seaburg, head of equity sales trading with Cowen & Co.”From a valuation perspective, this is not […]

This is your big chance to buy biotech, traders say

In fact, biotech stocks have been so strong that “you could see these stocks off another 10 percent from here, and still be in an uptrend,” Johnson said. “We’d be buying these names on the pullback.”The fundamentals also remain supportive of biotech, says David Seaburg, head of equity sales trading with Cowen & Co.”From a valuation perspective, this is not […]

Stock Market News for March 03, 2015 – March 3, 2015 – Zacks.com

Nasdaq closed above the 5000 mark for the first time since Mar 2000 boosted by a new deal in technology sector. The Dow and the S&P 500 also touched record highs as the US economy is seen to be gradually picking pace. Markets ended in the green, despite reports of slowdown in manufacturing activity and consumer spending. Meanwhile, interest cuts […]

Receptos CEO: Building for the long term – CNBC.com

Who can beat the ‘superbug’?
A new antibiotic-resistant “superbug” may have contributed to the deaths of 2 patients at Ronald Reagan-UCLA Medical Center. What companies may be on track to combat the deadly virus, with CNBC’s Meg Tirrell.
A year ago, Receptos was a billion-dollar company looking to compete with drugmakers sometimes a hundred times its size, in therapeutic areas already served […]

The Small-Cap Biotech Stock You Should Be Watching

Small-cap biotechnology stocks offer some of the most breathtaking opportunities in the market, but some are better than others. For example, these three tiny biotech stocks are favorites among our Motley Fool experts, and that could mean they’re worth watching.Source: Portola Pharmaceuticals.: Warfarin’s decades long dominance as an anticoagulant used to treat heart disease and post-operative patients is waning, and […]

3 All-or-Nothing Biotech Stocks We're Closely Watching

There may be no other industry as prone to hit-or-miss investments as biotechnology. An astounding 90% of drugs that enter phase 1 clinical trials never reach commercialization, and that means failure is far more common than success. As a result, many biotech companies research a slate of drugs in hopes of having at least one pan out. That’s not the […]

3 Small-Cap Biotech Stocks That Could Be Top Stocks in 2015

Source: Flickr user stockmonkeys.com .The pop-and-drop nature of the biotech industry makes owning stocks in the sector particularly dicey. But for investors willing to take on the risk of failure, a number of intriguing small-cap biotech companies are working on important new therapies that could make a big impact on patients’ lives and investors’ wallets. Here are three of thesecompanies.No. […]